Clinical Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, Automated ELISA, Software), End User (Hospital Laboratories, Diagnostic Laboratories) – Global Forecast to 2030

Clinical Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, Automated ELISA, Software), End User (Hospital Laboratories, Diagnostic Laboratories) – Global Forecast to 2030

Clinical Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, Automated ELISA, Software), End User (Hospital Laboratories, Diagnostic Laboratories) – Global Forecast to 2030

The global clinical lab automation market is projected to reach $3.72 billion by 2030, at a CAGR of 7.8% from 2023 to 2030.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Furthermore, increasing demand for automated instruments due to technological advancements, efficiency, and accuracy; technological advancements in molecular diagnostics; and emerging economies provide significant growth opportunities for this market.

However, the high costs of advanced clinical lab automation equipment and funding and infrastructure limitations in developing countries may restrain the growth of this market. Additionally, equipment maintenance and repair costs and concerns over the security and privacy of patient data pose a major challenge for the players operating in this market.

Among products, in 2023, the systems segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to the increased focus on drug development, and the advantages of automated liquid handling systems to increase efficiency and productivity while reducing errors.

Among end users, in 2023, the hospital laboratories segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to factors such as rising healthcare expenditures, continuous improvements in healthcare infrastructure, and the utilization of advanced techniques and technologies.

An in-depth analysis of the geographical scenario of the global clinical lab automation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the global clinical lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global clinical lab automation market.

The key players operating in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).

Scope of the Report:

Clinical Lab Automation Market Assessment–by Product

Systems
Automated Liquid Handling Systems
Automated ELISA Systems
Automated Nucleic Acid Purification Systems
Automated Microplate Readers
Other Systems
Clinical Lab Automation Software

Note:Other systems include automated incubators, automated cell counters, and cell imaging systems.

Clinical Lab Automation Market Assessment–by End User

Hospital Laboratories
Diagnostic Laboratories
Other End Users

Note:Other end users include blood banks, forensic labs, and clinical research organizations

Clinical Lab Automation Market Assessment–by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Clinical Lab Automation Market - Report Summary

Report Metrics	Details
Base Year	2022
Forecast Period	2023-2030
Page Count	209
Units Referenced	Revenue in US $ Million and Volume in Million lbs
Regions Covered	North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa.
Key Companies Mentioned	Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.)

FAQs About the Report

What is the scope of the clinical lab automation market study?

This market study covers the market sizes & forecasts of the clinical lab automation market based on product, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the clinical lab automation market at the regional and country levels.

What is the revenue generated from the sale of clinical lab automation products across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The clinical lab automation market is projected to reach $3.72 billion by 2030, at a CAGR of 7.8% during the forecast period of 2023–2030.

What are the various products of clinical lab automation, and which product segment holds the major share market?

Based on product, the clinical lab automation market is segmented into systems and clinical lab automation software. In 2023, the systems segment is expected to account for the largest share of the clinical lab automation market due to the increased focus on drug development, the advantages of automated liquid handling systems, and increased efficiency and productivity of samples and the laboratory while reducing errors.

What are the various end users in the clinical lab automation market, and which end user segment holds the major share of the market?

Based on end user, the clinical lab automation market is segmented into hospital laboratories, diagnostic laboratories, and other end users. In 2023, the hospital laboratories segment is expected to account for the largest share of the clinical lab automation market due to the rising healthcare expenditures, increasing prevalence of chronic diseases, increasing sample loads in hospitals, and improving healthcare infrastructure in developing countries by adopting advanced technologies.

What are the key factors supporting the growth of this market? What are the major opportunities for the market players in the clinical lab automation market?

The growth of this market is driven by the rising global geriatric population, the increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments.

Furthermore, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to provide significant growth opportunities for the players operating in this market.

What are the factors hindering the growth of the clinical lab automation market?

The high costs of advanced clinical lab automation equipment and funding and infrastructure limitations in developing countries are expected to hinder the growth of this market to a certain extent. In addition, factors such as high equipment maintenance and repair costs and concerns over the security and privacy of patient data are the major challenges to the growth of this market.

Who are the major players operating in the clinical lab automation market?

The key players operating in the clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the clinical lab automation market?

The Asia-Pacific region is slated to witness the fastest growth rate during the forecast period and subsequently offer significant growth opportunities for the players operating in this market. The high market growth in Asia-Pacific is driven by the increasing investment by healthcare providers towards infrastructure improvement, the need to manage the growing burden of infectious diseases, the rising demand for clinical testing, supportive government initiatives to improve the accessibility to diagnostic services, and the need to establish more diagnostic laboratories.